Fig. 3From: Nanoscale, antigen encounter-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatmentModulation of cellular function by RB‐312. IL-12/p70, IFN‐γ, TNF‐α and IL‐2 secretion after 48-h stimulation with FaDu cells (A) or MDA-MB-231 cells (C) at 1:1 E:T ratio and cytotoxic activity and CAR‐T cell expansion were monitored at day 3 and 6 (B, D)Back to article page